[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 860
6. Zhu LC, Yim J, Chiriboga L, Cassai ND, Sidhu GS, Moreira AL: DC-LAMP stains pulmonary adenocarcinoma with bronchiolar Clara cell differentiation. Hum Pathol; 2007 Feb;38(2):260-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] DC-LAMP stains pulmonary adenocarcinoma with bronchiolar Clara cell differentiation.
  • DC-LAMP marks pulmonary adenocarcinomas that show Clara cell characteristics by electron microscopy.
  • DC-LAMP staining was lost in solid type adenocarcinomas but persisted in well-differentiated areas.
  • DC-LAMP and CC-10 reactivity was also observed in endometrial adenocarcinomas but not in other tumor types.
  • [MeSH-major] Adenocarcinoma / pathology. Bronchi / pathology. Lung Neoplasms / pathology. Lysosome-Associated Membrane Glycoproteins / analysis
  • [MeSH-minor] Aged. Aged, 80 and over. Antibodies, Monoclonal / immunology. Carcinoma, Small Cell / metabolism. Carcinoma, Small Cell / pathology. Carcinoma, Squamous Cell / metabolism. Carcinoma, Squamous Cell / pathology. Cell Differentiation. Endometrial Neoplasms / metabolism. Endometrial Neoplasms / pathology. Female. Humans. Immunohistochemistry. Lung / chemistry. Lung / pathology. Lung / ultrastructure. Male. Microscopy, Electron. Middle Aged. Nuclear Proteins / analysis. Prognosis. Pulmonary Surfactants / analysis. Survival Rate. Transcription Factors / analysis

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17056097.001).
  • [ISSN] 0046-8177
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Lysosome-Associated Membrane Glycoproteins; 0 / Nuclear Proteins; 0 / Pulmonary Surfactants; 0 / Transcription Factors; 0 / thyroid nuclear factor 1
  •  go-up   go-down


7. Hu K, Zhong G, He F: Expression of estrogen receptors ERalpha and ERbeta in endometrial hyperplasia and adenocarcinoma. Int J Gynecol Cancer; 2005 May-Jun;15(3):537-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of estrogen receptors ERalpha and ERbeta in endometrial hyperplasia and adenocarcinoma.
  • We assessed the expression of estrogen receptors (ER)alpha and ERbeta in 114 human endometrial hyperplasia and adenocarcinomas.
  • The aim of this study was to determine the expression of both ER isoforms in human endometrial tissue by immunohistochemistry.
  • In atypia hyperplasia and adenocarcinoma, both ERalpha and ERbeta were decreased significantly (P < 0.05).
  • Most endometrial adenocarcinomas expressed ERalpha, either alone or in combination with ERbeta, and the ERbeta/ERalpha ratio was decreased when compared to normal proliferation (P < 0.05).
  • Also, we found that the expression of ERalpha and ERbeta has no relationship with the status of lymph node of adenocarcinoma (P > 0.05).
  • Both ERalpha and ERbeta play an important role in endometrial hyperplasia and carcinomas, the levels of ERalpha and ERbeta appear be used as prognostic indicators.
  • [MeSH-major] Adenocarcinoma / genetics. Adenocarcinoma / pathology. Endometrial Hyperplasia / genetics. Endometrial Hyperplasia / pathology. Endometrial Neoplasms / genetics. Endometrial Neoplasms / pathology. Estrogen Receptor alpha / biosynthesis. Estrogen Receptor beta / biosynthesis. Gene Expression Profiling

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15882182.001).
  • [ISSN] 1048-891X
  • [Journal-full-title] International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • [ISO-abbreviation] Int. J. Gynecol. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Estrogen Receptor alpha; 0 / Estrogen Receptor beta; 0 / Protein Isoforms
  •  go-up   go-down


8. Salakos N, Bakalianou K, Deligeoroglou E, Kondi-Pafiti A, Papadias K, Creatsas G: Endometrial carcinoma presenting as hematometra: clinicopathological study of a rare case and literature review. Eur J Gynaecol Oncol; 2007;28(3):239-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endometrial carcinoma presenting as hematometra: clinicopathological study of a rare case and literature review.
  • From her clinical history, a wide excision of the uterine cervix was reported due to a high-grade intraepithelial squamous neoplasia.
  • Laparotomy showed a greatly enlarged uterus and the histological exam revealed a hematometra with a superficial endometrioid adenocarcinoma of the uterine cavity.
  • A review of the literature revealed that hematometra in postmenopausal women should be investigated because it may harbor a cancer.
  • [MeSH-major] Adenocarcinoma / pathology. Adenocarcinoma / surgery. Endometrial Neoplasms / pathology. Endometrial Neoplasms / surgery. Postmenopause
  • [MeSH-minor] Aged. Diagnosis, Differential. Female. Hematometra / diagnosis. Humans. Neoplasm Staging. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17624098.001).
  • [ISSN] 0392-2936
  • [Journal-full-title] European journal of gynaecological oncology
  • [ISO-abbreviation] Eur. J. Gynaecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


9. Liao CL, Lee MY, Tyan YS, Kok LF, Wu TS, Koo CL, Wang PH, Chao KC, Han CP: Progesterone receptor does not improve the performance and test effectiveness of the conventional 3-marker panel, consisting of estrogen receptor, vimentin and carcinoembryonic antigen in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study. J Transl Med; 2009;7:37
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Progesterone receptor does not improve the performance and test effectiveness of the conventional 3-marker panel, consisting of estrogen receptor, vimentin and carcinoembryonic antigen in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study.
  • OBJECTIVE: Endocervical adenocarcinomas (ECA) and endometrial adenocarcinomas (EMA) are uterine malignancies that have differing biological behaviors.
  • [MeSH-major] Biomarkers, Tumor / metabolism. Carcinoembryonic Antigen / metabolism. Endometrial Neoplasms / metabolism. Receptors, Estrogen / metabolism. Receptors, Progesterone / metabolism. Uterine Cervical Neoplasms / metabolism. Vimentin / metabolism
  • [MeSH-minor] Diagnosis, Differential. Female. Humans. Immunohistochemistry. Sensitivity and Specificity. Tissue Array Analysis


10. Srikantia N, B R, A G R, Kalyan SN: Endometrioid endometrial adenocarcinoma in a premenopausal woman with multiple organ metastases. Indian J Med Paediatr Oncol; 2009 Apr;30(2):80-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endometrioid endometrial adenocarcinoma in a premenopausal woman with multiple organ metastases.
  • Endometrial adenocarcinoma is the third common malignancy of the female genital tract occurring most often in the postmenopausal age group.
  • We present an unusual case of endometrial adenocarcinoma in a premenopausal woman with simultaneous metastases in brain, liver, skin and skeletal system, within one month of completion of treatment.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Gynecol Oncol. 1997 Jun;65(3):530-3 [9190989.001]
  • [Cites] Int J Gynecol Pathol. 2002 Jul;21(3):281-4 [12068176.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):168-73 [15093913.001]
  • [Cites] Gynecol Oncol. 2004 May;93(2):524-8 [15099973.001]
  • [Cites] Expert Rev Anticancer Ther. 2004 Aug;4(4):679-89 [15270671.001]
  • [Cites] Gynecol Oncol. 2004 Aug;94(2):333-9 [15297170.001]
  • [Cites] Gan To Kagaku Ryoho. 2008 Sep;35(9):1488-94 [18799902.001]
  • [Cites] Anticancer Res. 2009 May;29(5):1715-20 [19443392.001]
  • (PMID = 20596308.001).
  • [ISSN] 0975-2129
  • [Journal-full-title] Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology
  • [ISO-abbreviation] Indian J Med Paediatr Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2885881
  • [Keywords] NOTNLM ; Adjuvant chemotherapy / endometrial carcinoma / multiple organ metastases
  •  go-up   go-down






Advertisement